Brainstorm announces upcoming scientific conference presentations

Data on msc-ntf exosome technology at isct 2022 and isev 2022 conferences nurown® cfs biomarker analysis to be presented at als drug development summit new york , may 3, 2022 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative diseases, today announces presentations at upcoming scientific conferences in may 2022.  new data on the company's proprietary msc-ntf exosome technology will be presented at isct 2022 (may 4 to 7 in san francisco, ca) and at the isev 2022 annual meeting (may 25 to 29 in lyon, france).
BCLI Ratings Summary
BCLI Quant Ranking